Belite Bio submits drug applications in Singapore, UK, Switzerland
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
What's breaking now, across thousands of outlets.
We haven't written up this one. Investing.com has the full story — the link below goes straight to it.
Aliko Dangote says investors applying with N50,000 or less will get priority in the Dangote Refinery initial public offering to widen participation.